Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon

✍ Scribed by Bielekova, B.; Richert, N.; Howard, T.; Blevins, G.; Markovic-Plese, S.; McCartin, J.; Wurfel, J.; Ohayon, J.; Waldmann, T. A.; McFarland, H. F.; Martin, R.

• Book ID: 126716734
• Publisher: National Academy of Sciences
• Year: 2004
• Tongue: English
• Weight: 320 KB
• Volume: 101
• Category: Article
• ISSN: 0027-8424
• DOI: 10.1073/pnas.0402653101